VZV gE

Jiehui Wu1, Hai Li2, Yanping Yuan1

  • 1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Vaccines
|October 26, 2024
PubMed
概括

这项研究探讨了用于疹病毒 (HZ) 复合疫苗的截断的葡萄糖蛋白E (gE) 蛋白. tgE350蛋白有效诱导VZV特异性抗体和中和小鼠的免疫反应.